May 31, 2020
Research scheduled to be presented at the cancelled Digestive Disease Week conference in Chicago, USA in early May 2020 has assessed of specific aspect of safety data on on over 19,000 patients in the famous Aspree study, where just over 9,500 patients were assigned...
May 30, 2020
The effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on renal outcomes in routine clinical practice have been investigated in a Scandinavian cohort study. 29,887 new users of SGLT2 inhibitors (such as dapagliflozin, empagliflozin and canagliflozin) were...
May 25, 2020
Pregabalin is a commonly prescribed drug – among other applications it is used to treat neuropathic pain, fibromyalgia and partial seizures> The euphoric and relaxing effects of this drug have led to increased recreational use, overdoses and death. An...
May 22, 2020
Potentially inappropriate medications (PIMs) pose greater risk of harm than benefit, especially when prescribed for patients aged 65 years and over. Hospitalisation provides an opportunity for medication review – while some PIMs are deprescribed or replaced...
May 20, 2020
A new retrospective analysis of the incidence, type and risk factors associated with adverse drug reactions (ADRs) in COVID-19 patients has been published from China. The study used active monitoring of the China Hospital Pharmacovigilance System (CHPS) to detect ADR...
